Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Rin Nagaoka"'
Autor:
Hiroki Odawara, Mami Kikuchi, Jun Horiguchi, Hideaki Tokiniwa, A. Sato, Nana Rokutanda, Daisuke Takata, Rin Nagaoka, Izumi Takeyoshi
Background: S-1 and cyclophosphamide (CPA) can be given orally, and their combination may have great potential for treating metastatic breast cancer (MBC). A phase I study of sequential S-1 and CPA therapy was conducted in patients with MBC; the reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80e5c481c93f3cbbcfe7e0eaf1421087
https://doi.org/10.21203/rs.3.rs-22934/v3
https://doi.org/10.21203/rs.3.rs-22934/v3
Autor:
Daisuke Takada, Tetsunari Oyama, Shuichi Okada, Tsugumichi Saito, Nobuyuki Shibusawa, Jun Horiguchi, Sumiyasu Ishii, Atsushi Ozawa, Akiko Katano-Toki, Eijiro Yamada, Rin Nagaoka, Shunichi Matsumoto, Satoshi Yoshino, Takashi Okamura, Tetsurou Satoh, Takuya Tomaru, Masanobu Yamada, Yasuyo Nakajima, Kazuhiko Horiguchi
Publikováno v:
Endocrine Journal. 64:39-47
Somatic mutations in KCNJ5 gene have been identified in patients with adrenal aldosterone-producing adenomas (APAs). We previously reported that Japanese patients with APAs had distinct characteristics from patients in Western countries; i.e. they ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1855053f38f4a1680bc26b2078b47756
https://doi.org/10.1507/endocrj.ej16-0243
https://doi.org/10.1507/endocrj.ej16-0243
Autor:
Hiroyuki Kuwano, Hideaki Tokiniwa, Jun Horiguchi, Toru Higuchi, Reina Yajima, Daisuke Takata, Takaaki Fujii, Rin Nagaoka, Sasagu Kurozumi, Sayaka Obayashi
Publikováno v:
Anticancer Research. 36:5481-5486
The diagnostic utility of 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) for breast cancer is controversial. The histological type or tumor size of breast cancer has been reported to be associated with a greater likelihood of positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de5a6ba3c6a18629faf1941e287da906
https://doi.org/10.21873/anticanres.11129
https://doi.org/10.21873/anticanres.11129
Autor:
Izumi Takeyoshi, Daisuke Takata, Hideaki Tokiniwa, Tetsunari Oyama, Jun Horiguchi, A. Sato, Nana Rokutanda, Mio Furuya, Rin Nagaoka, Sayaka Uchida, Yukio Koibuchi
Publikováno v:
International Cancer Conference Journal. 4:52-56
Primary thyroid angiosarcoma is a very rare and aggressive disease, originally reported in patients from the Swiss Alpine region, but is rare in other parts of the world. We describe a Japanese case of primary angiosarcoma of the thyroid in a 64-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e062764a708f6f771bc02aacf26e8bd
https://doi.org/10.1007/s13691-014-0170-x
https://doi.org/10.1007/s13691-014-0170-x
Autor:
Daisuke Takada, Hideaki Tokiniwa, Miho Yoshida, Nawa Rokutanda, Masami Sunaga, Michio Maemura, Mami Kikuchi, Izumi Takeyoshi, Tsunehiro Ishida, Jun Horiguchi, Rin Nagaoka, Yuichi Iino, Keiichi Endo, Aya Sato, Takao Yokoe, Takayuki Kano, Yukio Koibuchi, Shoichi Aiba, Fumihiro Ikeda
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 23:98-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28a0c777fd83d3d7dc98d7ecfb8b5625
https://doi.org/10.3804/jjabcs.23.98
https://doi.org/10.3804/jjabcs.23.98
Autor:
Hideaki Tokiniwa, Hotaka Yamazaki, Yutaka Sunose, Norifumi Takahashi, Izumi Takeyoshi, Keitaro Hirai, Hiroomi Ogawa, Rin Nagaoka, Kengo Takahashi, Takamichi Igarashi, Hiroshi Tsukagoshi, Daisuke Yoshinari, Nana Rokutanda, Kazumi Tanaka
Publikováno v:
The Kitakanto Medical Journal. 63:339-343
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7b13afdb8789d72591c499b85e9e2df
https://doi.org/10.2974/kmj.63.339
https://doi.org/10.2974/kmj.63.339
Autor:
Katsunori Tozuka, A. Sato, Hideaki Tokiniwa, Daisuke Takata, Izumi Takeyoshi, Tetsunari Oyama, Nana Rokutanda, Jun Horiguchi, Rin Nagaoka, Mami Kikuchi
Publikováno v:
Cancer Research. 72:P3-06
Background: Circulating tumor cells (CTCs) in peripheral blood may represent the possible presence of early tumor dissemination. However, relatively few studies were designed to investigate the change of CTC status by adjuvant chemotherapy in operabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::effd0b05ef24731b8ea9a7828cacc526
https://doi.org/10.1158/0008-5472.sabcs12-p3-06-29
https://doi.org/10.1158/0008-5472.sabcs12-p3-06-29
Autor:
Nana Rokutanda, Hideaki Tokiniwa, A. Sato, Katsunori Tozuka, Daisuke Takata, Izumi Takeyoshi, Jun Horiguchi, Sayaka Uchida, Rin Nagaoka
Publikováno v:
Cancer Research. 72:P2-05
Background: Recently, it is a hot topic that the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor type 2 (HER2) may differ between the primary tumors and the paired recurrent metastatic tumors. On the othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::611ef92bd9f1ffc9cdd1954a19e4efdd
https://doi.org/10.1158/0008-5472.sabcs12-p2-05-07
https://doi.org/10.1158/0008-5472.sabcs12-p2-05-07
Autor:
Takaaki, Fujii, Reina, Yajima, Miki, Tsuboi, Toru, Higuchi, Sayaka, Obayashi, Hideaki, Tokiniwa, Rin, Nagaoka, Daisuke, Takata, Jun, Horiguchi, Hiroyuki, Kuwano
Publikováno v:
Anticancer research. 36(6)
Several studies have reported that high F18-fluorodeoxyglucose (FDG) uptake is predictive of poor prognosis and aggressive features in patients with breast cancer. While these studies evaluated the prognostic value for cases with high FDG uptake, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ca2d548c0ab01981c800c2495b47f4f
https://pubmed.ncbi.nlm.nih.gov/27272820
https://pubmed.ncbi.nlm.nih.gov/27272820
Autor:
Ayako Satou, Mami Kikuchi, Hiroyuki Takei, Daisuke Takata, Rin Nagaoka, Izumi Takeyoshi, Hideaki Tokiniwa, Nana Rokutanda, Jun Horiguchi, Katsunori Tozuka
Publikováno v:
Molecular and Clinical Oncology. 1:93-99
Anthracyclines and taxanes are standard anticancer drugs used in breast cancer chemotherapy. In general, the efficacy of chemotherapy is lower in patients with estrogen receptor (ER)-positive tumors compared to patients with ER-negative tumors. Altho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3575c81628c800cd73080467db84bc04
https://doi.org/10.3892/mco.2012.4
https://doi.org/10.3892/mco.2012.4